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crustaceans, and consequent tolerance adaptations, as opposed to the toxic xenobiotic heavy metals Cd, Hg and Pb. Hyperglycaemic responses to both groups of heavy metals are not elicited in eyestalk-ablated animals, therefore, they involve MTXO-SG hormones, probably cHH.
However, in spite of the richness of information about blood glucose variation following stress, much less is known about the stress-induced variation of cHH content in the sinus gland and circulating in the haemolymph. In the crayfish Orconectes limosus undergoing hypoxia, cHH titres of around 120·pmol·l -1 are reached within 15·min (Keller and Orth, 1990) . In Cancer pagurus, emersion induced an increase of the haemolymph cHH after 4·h (Webster, 1996) . Chang et al. (1998) used ELISA to monitor the blood cHH variation in Homarus americanus following various environmental stresses. Emersion proved to be a potent stimulator for elevation of cHH, while temperature and salinity variations were less effective.
Moreover, in C. maenas it has been shown that the concentration of cHH in the haemolymph increases dramatically during moulting: from 1-5·fmol·100·µl -1 in the intermoult, up to 150-200·fmol·100·µl -1 during ecdysis (Chung et al., 1999) . More recently, variation of cHH titre was reported in the haemolymph of Nephrops norvegicus infected by the parasitic dinoflagellate Hematodinium sp. (Stentiford et al., 2001) . Finally, increased water temperature in Cancer pagurus and Procambarus clarckii induced an increment in blood cHH (Wilcockson et al., 2002; Zou et al., 2003) . The aim of this paper was to monitor the variation of cHH in the eyestalks and haemolymph of P. elegans (Decapoda, Caridea) following various stresses (heavy metals and LPS), and to relate cHH levels to the variation of amount and time course of blood glucose.
Materials and methods

Animal supply and maintenance
Specimens of Palaemon elegans (Rathke) (Decapoda, Caridea, (4) (5) (6) , an eurythermal and euryhaline species distributed widely along the coastal areas of Europe, were supplied by commercial fishermen and caught by cages in the Gulf of Trieste (Upper Adriatic Sea). They were stocked in 120·l glass tanks with closed-circuit (filtered and thoroughly aerated) 36% salinity artificial sea water (Prodac ® Padova, Italy), at 16-18°C, and a natural L:D photoperiod, 300 lux intensity (type 49 fluorescent tubes by Philips, Monza, Italy). They were fed ad libitum with bits of shrimp, cuttlefish or fish every second day; dead animals were removed daily. Apparently healthy animals of both sexes, non-ovigerous and intermoult, having a body weight 1-1.5·g were used. 48·h before use, animals were housed individually in 500·ml plastic net cages immersed in larger tanks, for individual recognition. From this point on, and during the experiments, the animals were not fed.
Haemolymph sampling and determination of glycaemia
The animals were blotted dry and haemolymph (50·µl) was withdrawn from the pericardial sinus into a sterile 1·ml syringe fitted with 25·g needles. Animals (N=10 for each treatment) were bled at 0·h, usually between 9-10 a.m., to reduce possible interference due to circadian change in blood-glucose level (Kallen et al., 1990) .
Haemolymph glucose content was quantified by using One touch ® II Meter (Lifescan, Miltipas, CA, USA) and commercial kit test strips (precision of strips±3% coefficient of variation in the tested range). Owing to the speed of processing, no anticoagulant was needed. In the results, variations of glycaemia defined as increments are given as the mean of: [(experimental value)/(value displayed by the same animal at 0·h)]-1. -1 , administered as CuCl 2 ) in seawater, and the controls maintained in uncontaminated water. At 0, 0.5, 1, 2, 3 and 24·h after exposure to heavy metals, animals were bled as described above.
Effect of HgCl
For LPS, groups of 10 animals were injected with 0.1 and 2·mg·g -1 live weight of LPS from Escherichia coli 0111:B4; variation of glycaemia was determined as described above at 0, 0.5, 1, 2, 3, 5 and 24·h. Control groups injected with saline were tested at the same time; sterile saline for marine crustaceans was prepared with pyrogen-free distilled water and analytical grade chemicals, according to Smith and Ratcliffe (1978) and autoclaved for 25·min. All reagents were supplied by Sigma-Aldrich (St Louis, Missouri, USA).
Eyestalk homogenate and haemolymph treatment for ELISA measurement of cHH variation Groups of 10 P. elegans were exposed to Hg 2+ (0.1, 0.5 and 5·mg·l -1 ), Cu 2+ (0.1 and 5·mg·l -1 ) or injected with LPS (0.1 and 2·mg·g -1 live weight); untreated animals and saline-injected animals were used as controls. Eyestalks were removed at time 0 and then at 0.5, 1, 2 and 3·h of exposure (and at 5·h only for LPS) from the 10 animals of each different experimental group. Animals were anaesthetized for 1·min on ice before ablation. The eyestalk was quickly frozen and the pigmented eyecup dissected. Eyestalk homogenate was prepared from 20 eyestalks homogenized in 2·ml cold phosphate-buffered saline (PBS Sigma) pH·8.0, and then centrifuged for 1·h at 930 ·g and 4°C, and the pellet discarded. Homogenates were quickly deep frozen at -20°C and stored until required for study.
Haemolymph was withdrawn from different groups of 10 P. elegans for each treatment and time, as described above at time 0 and then at 0.5, 1, 2 and 3·h (and at 5·h only for LPS), immediately centrifuged for 1·min at 10,300·g and 4°C, and the supernatants then stored at -20°C.
Direct enzyme-linked immunosorbent assay (ELISA) of cHH
The samples of eyestalk homogenate were always tested at Stress-induced variations in shrimp hyperglycemic hormone (Mettulio, 2002) . 100·µl of the samples (eyestalk homogenate, or haemolymph, from the different treatments and standards) were loaded onto a 96-microwell plate (Costar, Bethesda, MD, USA) and incubated in duplicate overnight at 4°C. The content of the wells was discarded and the wells were washed four times with 250·µl of PBS-T (PBS+0.1% Tween20, pH·7.4), then filled with 100·µl of 3% bovine serum albumine (BSA, Sigma) solution in PBS pH·7.4 plus 5% foetal calf serum (FCS, Sigma) and left for 2·h at room temperature (RT). The content was discarded and the plates washed four times as described above. 100·µl of the biotinylated anti-NencHH (anti N. norvegicus cHH; Giulianini et al., 2002) antibody (1·µg·µl -1 ) diluted 1:1000 was then added to each well and the plate was incubated for 3·h at 36°C.
After removal of the biotinylated antibody, plates were washed extensively with PBS-T, followed by the addition of 100·µl of streptavidin-peroxidase solution (Sigma) diluted 1:5000 and incubated for 1·h at RT. The plates were once again washed four times with PBS-T and developed with 2,2′-azinobis-3-ethylbenz-thiazoline-6-sulphonic acid solution (Sigma; liquid substrate ready for use) in darkness for 1·h at RT (100·µl per well). The absorbance was measured in a multiwell plate reader (Anthos 2020 version 1.1; Krefeld, Germany) at 405·nm. Fig.·1 presents an example of the standard curve obtained from dilutions of a known amount of a 6ϫHis-NencHHwt. The graph shows the mean and standard deviations (after subtraction of the background absorption) of the quadruplicate determinations of recombinant cHH plotted against the optical density (OD) with the calculated linear regression (Fig.·1) . Sample values were then inserted into the equation and the amount of unknown cHH thereby determined.
Statistical analysis
All statistics were performed by using a SPSS 9 ® (SPSS Inc., Chicago, IL, USA) for Windows package, and data are given as arithmetic means ± S.D. Effects of experimental treatments on blood glucose levels were analysed. Analysis of variance (ANOVA) and Student's t-test were used to test the null hypotheses that all treatment means were equal, and then all the data were tested by the LSD and Dunnett post hoc test. The levels of significance were then calculated by Student's t-test for paired or independent data. A probability value of <0.05 of the statistical tests between the control and experimental values (mean ± S.D.) was considered significant. To test the statistical significance of ELISA values compared between experiments, Student's t-test was used at P<0.05. Time scale of graphs is not proportional, to provide a better visual inspection of data and size of the illustration.
Results
The mean concentration of glucose in the haemolymph of untreated P. elegans was 10.06±2.22·mg·dl -1 (N=90). In untreated animals bled at times 0, 0.5, 1, 2, 3, 5 and 24·h, no significant (P>0.05) variation of blood glucose was revealed compared with time 0 value of 10.70±3.06·mg·dl -1 (N=10; data included in Fig.·10 ). Control animals injected with saline (N=10) reached a peak of glycaemia (see Materials and methods) of 0.37±0.22 (12.90±2.32·mg·dl -1 ) 2·h after injection, which is significantly (P=0.014) different from the initial value of 9.70±2.91·mg·dl -1 . Thereafter, the glucose level returned to the initial level until the end of the experiment. No significant difference in variation of glycaemia (P>0.05) was noticed between the control animals that were bled only and those that were treated with saline (data included in Fig.10 ). The latter more-conservative control was used throughout for statistical comparison. In untreated animals, the cHH resting level in the eyestalk was 5.60±2.6·pmol·SGe -1 (N=14) and in the haemolymph it was 1.13±0.28·pmol·ml -1 (N=11), and these baseline values were used as the control for experimental animals exposed to heavy metals.
In animals injected with saline, the level of cHH in the eyestalk reached a minimum of 5.3±1.7·pmol·SGe -1 (N=3) 1·h after injection, a value that was not significantly different from the resting value of the untreated animals (P=0.855); in the haemolymph, a maximum of circulating cHH of 1.23±0.603·pmol·ml -1 was detected 30·min after injection of saline, which was not significantly different (P=0.930) from the resting value of untreated animals. Sterile saline was also used as control for animals injected with LPS. Fig.·2 , where 0.1·mg·l -1 is a sublethal concentration and 5·mg·l -1 is a lethal concentration (as determined by Lorenzon et al., 2000) .
The highest Cu 2+ concentration induced a massive release of cHH from the sinus gland. After 30·min the cHH content is 0.71±0.21·pmol·SGe -1 , significantly lower (P=0.006) than in the untreated controls (used as time 0) and the hormone level reached a minimum of 0.45±0.27·pmol·SGe -1 (P=0.004 vs control) after 2·h. Thereafter, the cHH started to recover with a content of 2.70±3.94·pmol·SGe
-1 detected 3·h after exposure and not significantly different (P=0.126) from the control.
The Cu 2+ concentration of 0.1·mg·l -1 (Fig.·2 ) caused a gradual release of cHH. The value of cHH decreased to 3.37±2.99·pmol·SGe
-1 1·h after exposure, which is not significantly different from the control (P=0.207). At 2·h, the significant minimum content of cHH of 2.29±0.81·pmol·SGe -1 (P=0.04) was reached. Thereafter, from 3·h onwards the cHH titre returned to the pre-treatment level of 5.04±4.90·pmol·SGe -1 (P=0.774 vs untreated control). Exposure to Cu 2+ 5·mg·l -1 caused a significant elevation of haemolymph cHH (Fig.·3 ) that rose up to 8.67±2.99·pmol·ml -1 after 2·h, a value that was significantly different (P=0.001) from that of the untreated animals (1.13±0.28·pmol·ml -1 ). The circulating cHH remained significantly (P<0.05) high throughout the experimental period. In animals exposed to the lowest Cu 2+ concentration, the blood cHH remained on resting levels and only after 2·h increased slightly, but significantly (P=0.013 vs control), up to 1.68±0.34·pmol·ml -1 . Exposure of P. elegans to Cu 2+ induced a dose-related release of cHH from eyestalk to haemolymph. Fig.·4 shows the consequent dose-related variation of glycaemia. At the highest concentration, in the first 3·h after exposure, a significant increase in blood glucose became evident, with a peak of increment of 2. 60±0.49 (33.80±4.89·mg·dl -1 ) at 2·h that was significantly different from the initial value (9.50±1.65·mg·dl -1 ; P=0.001) and also from the control at the same time (13.30±2.75·mg·dl -1 ; P=0.001). Animals exposed to 0.1·mg·l -1 Cu 2+ showed a similar time course of hyperglycaemia but with a lower increment in blood glucose. A maximum increment of 0. 77±0.25 (15.00±1.49·mg·dl -1 ) was revealed at 2·h, which is significantly different from the control (13.30±2.75·mg·dl -1 ; P=0.046) and from the value at the higher concentration (P=0.001) at the same time. Fig.·5 shows the time course of cHH eyestalk content after exposure of P. elegans to Hg 2+ at the sublethal concentrations (as defined by Lorenzon et al., 2000) of 0.1 and 0.5·mg·l -1 , and at a lethal concentration of 5·mg·l -1 , compared with the untreated control. At the lethal concentration, a rapid and massive release of cHH from the sinus gland became evident; in fact after 30·min from exposure, the hormone content decreased to 1.22±0.39·pmol·SGe (Fig.·6) , at the concentration of 5·mg·l -1 , induced a rapid increase of cHH concentration in the haemolymph with a peak of 5.90±0.68·pmol·ml -1 after 1·h that was significantly different (P=0.001) from the unexposed control (1.13±0.28·pmol·ml -1 ). Thereafter, the circulating cHH remained significantly (P<0.05) higher than in the control. The intermediate concentration was most effective in elevating blood cHH: the hormone concentration rapidly increased and remained significantly (P<0.05) higher than in control group, with a maximal concentration of circulating hormone (6.92±1.27·pmol·ml
-1 ) at 2·h (Fig.·6) . At the lowest Hg 2+ concentration (0.1·mg·l -1 ), a significant increase (P<0.05) of circulating cHH was recorded 1 and 2·h after exposure with a maximum of 2.14±0.74·pmol·ml (Fig.·8 ). After 30·min, the hormone level was 0.26±0.03·pmol·SG -1 , which is significantly different from the initial value of 5.60±2.6·pmol·SG -1 (P=0.003) and from the saline control at the same time point (5.47±1.86·pmol·SGe -1 ; P=0.008). After 3·h, the cHH level rose, slightly, to 0.75±0.14·pmol·SGe -1 and, eventually, 5·h after injection the hormone content was 1.42±0.39·pmol·SGe -1 , which was still significantly lower (P=0.007 and P=0.016, respectively) than the saline control. The lower dose of 0.1·mg·g -1 (Fig.·8 ) induced the cHH release in the first hour after injection, with a minimum eyestalk content, revealed at 30·min, of 2.39±0.93·pmol·SGe -1 , which is also significantly different from the saline control (P<0.05). Thereafter, we observed a gradual recovery of the hormone level. From 2·h onwards the cHH eyestalk content (4.11±2.59·pmol·SGe -1 ) was not significantly different from control (5.41±0.3·pmol·SGe -1 ; P=0.435) and after 5·h the value returned back to a normal resting value of 5.21±1.23·pmol·SGe -1 (P=0.804 vs control). Following the massive cHH release from the eyestalk in animals that had been treated with 2·mg·g -1 of LPS (Fig.·9 ), high levels of circulating hormone were detected in the haemolymph. After 30·min, the cHH level rose to 7.12±1.81·pmol·ml -1 , which was significantly different from the initial value in untreated (P=0.001) animals (1.13±0.28·pmol·ml -1 (P=0.001 vs saline control) at 3·h and to 2.02±0.16·pmol·ml -1 after 5·h, which is still significantly higher than control (P=0.001). In animals injected with 0.1·mg·g -1 of LPS (Fig.·9) , an increase in circulating cHH was detected from 30·min with a significant (P=0.001 vs control) peak of 4.47±1.26·pmol·ml -1 at 1·h, then the level decreased and after 3·h there was no significant difference from the control (P>0.05; Fig.·9 ).
Blood glucose variation after injection of LPS (Fig.·10 ) follows the time course of haemolymph cHH. At the highest dose, from 30·min after injection, an increment of glycaemia of 1.55±1.09 (26.90±12.40·mg·dl -1 ) is revealed -a concentration that was significantly different from initial value (10.70±2.71·mg·dl -1 ; P=0.001) and from the control at the same time (11.40±2.37·mg·dl -1 , P=0.001). At 2·h, injected animals showed a peak of increment of 4.79±2.06 (58.90±16.93·mg·dl -1 ), and in the next 24·h blood glucose level gradually recovered to resting values. The lower dose (0.1·mg·g -1 ) induced a slight hyperglycaemia at 1·h with a maximal increment of 1. 22±0.44 (19.10±4.01·mg·dl -1 ) significantly different from time 0 value (8.70±1.42·mg·dl -1 P=0.001) and from control (P=0.001). Thereafter, no significant variation (P>0.05) of blood glucose was recorded.
Discussion
This paper describes (using ELISA and bioassays) the relationship between environmental stress, the release of cHH from the eyestalk into the haemolymph and the hyperglycemic response in the shrimp Palaemon elegans. Moreover, this work validates the use of a cross-reactive antibody anti-NencHH (Giulianini et al., 2002) to assess cHH content in the eyestalk and haemolymph of P. elegans. Finally, this present study is the first, to our knowledge, to quantify the variation of cHH after a challenge with different stressors and to follow it through to its effects in the blood compartment.
The resting value of cHH in P. elegans eyestalk was found to be 5.6±2.6·pmol·SGe
-1 (62±29·ng·SGe -1 ), which is in the range of those already detected in other crustacean species. Huberman et al. (1995) identified in Procambarus bouvieri two isoforms of the cHH (cHH-I e cHH-II) in approximate concentrations of 60 and 20·ng·SG -1 , respectively. Chang et al. (1990) found in Homarus americanus a cHH content in the sinus gland of 3·pmol·SG -1 . More recently, Marco et al. (2000) quantified the content of cHH-I in the spiny lobster Jasus lalandii as 20·pmol·SG -1 and cHH-II as 3·pmol·SG -1 . In C. maenas and C. pagurus, a larger cHH content of 180·pmol·SG -1 and 125·pmol·SG -1 , respectively, was detected (Keller et al., 1985; Webster, 1996) . All former data were obtained by calibration on HPLC purified SG cHH and antibody raised against it. We are presently unable to relate immunoreactivity of our recombinant cHH and antibody with the natural purified neuropeptide. Because of cross immunoreactivity, western blotting, and similar distribution (Giulianini et al., 2002) and quantitative profiles, we are confident that immuno-localization and quantification is specific for the native cHH as well.
In P. elegans, exposure to Cu induced a dose-related rapid and massive release of cHH from the eyestalk into haemolymph at the higher, lethal concentration, whereas a gradual and reduced discharge was revealed at the lower concentration. The relationship between exposure to toxicant and release of cHH is confirmed by variation of blood glucose with a dose-related hyperglycaemia that peaked 2·h after exposure to Cu.
Animals exposed to previously defined (Lorenzon et al., 2000) sublethal concentrations of Hg showed the same quantitative and time-course relationships between toxicant and release of cHH from the eyestalk, increment of hormone level in the haemolymph and subsequent hyperglycaemia (as already described for Cu contamination). Interestingly, however, the highest, lethal concentration of 5·mg·l -1 (Lorenzon et al., 2000) induced the release of cHH from the eyestalk to the haemolymph but was not followed by a significant variation of blood glucose. This situation could be related to the high toxicity of Hg, which may interfere with the finer mechanisms that regulate the hyperglycaemic response. It is not caused by a synaptic blockage of the superimposed neuronal release network (Lorenzon et al., 1999) or to a limited release of circulating cHH because high levels of cHH are discharged from the SG into the blood compartment. Likewise, it is not due to inhibition of peripheral receptors on glucogenolytic target organs; indeed, native SG homogenate injected into eyestalk-less shrimps exposed to lethal Hg 2+ for 3·h can still cause hyperglycaemia (Lorenzon et al., 2000) . High concentrations of Hg, instead, may change the functionality of the prepro-cHH processed during secretory steps, due to Hg ability to bind cysteines -six of which represent a highly conserved feature of the peptide structure (Lacombe et al., 1999 ) -thereby altering the active conformation of the peptide, as seen in another system (Rodgers et al., 2001 ), but not its immunoreactivity. Moreover, Hg is known to impair osmoregulatory capability in the crab Eriocheir sinensis (Péqueux et al., 1996) ; and in P. clarkii Hg induces an inhibition of the acetylcholinesterase activity (Devi and Fingerman, 1995) . Therefore, the altered response in P. elegans exposed to high concentrations of Hg 2+ may be related to physiological modifications induced by Hg 2+ at a different systemic level.
Contamination with different doses of a bacterial thermostable endotoxin, such as LPS from E. coli, confirms the dose-related and convergent chain of events that bring about hyperglycaemia. It suggests that blood glucose elevation is a general purpose response to stressors and is likely to perform a protective role. Variation in the level of circulating cHH has been reported following exposure to various stresses. In Cancer pagurus, variation of haemolymph cHH is reported after emersion; hormone titre rapidly increases from undetectable levels to 30·pmol·l -1 after 4·h with a simultaneous increase of blood glucose (Webster, 1996) . Chang et al. (1998) used ELISA to measure the levels of circulating cHH in Homarus americanus following three different kinds of stress: emersion, temperature elevation and salinity change. Emersion was the most potent stimulator for the elevation of haemolymph cHH increasing the baseline values of 4·fmol·ml -1 to 168.1·fmol·ml -1 after 4·h; thermal and salinity stress caused only a slight increase in circulating hormone. In H. americanus, the maximum increment of glycaemia is reached at 2·h after emersion while the maximum cHH level in the haemolymph is revealed at 4·h. By contrast, in our experiment, the peak of circulating cHH precedes, or at least coincides with, the maximum level of blood glucose. Recently, Zou et al. (2003) demonstrated that variation of water temperature from 24 to 34°C increases cHH levels from 32.4±4.9·fmol·ml
-1 up to 123.3±21.1·fmol·ml -1 after 2·h in P. clarkii.
Variation of blood cHH has been reported during the moult of C. maenas (Chung et al., 1999) and, in particular, a dramatic increase of the cHH level became evident during ecdysis (from 1-5·fmol·100·µl -1 of intermoult to 200·fmol 100·µl -1 ). In this case, the release of cHH is not dependent on the eyestalk, as an increase in circulating cHH is revealed also in eyestalk-less animals and release from the gut-associated neuroendocrine tissue. However, additional eyestalk release could be related with the cells containing cHH, as identified by Chang et al. (1999) in the second roots of the thoracic ganglia and in the suboesophageal ganglion.
Infection of Nephrops norvegicus by the parasitic dinoflagellate Hematodinium sp. induces an elevation of the cHH titre in the haemolymph (Stentiford et al., 2001) . Concentration of blood hormone increases with the severity of the infection from 32.2·fmol·ml -1 in uninfected animals to 77.2 and 107.65·fmol·ml -1 . In this case, the concentration of glucose in the haemolymph is significantly reduced in infected animals, probably due to the use of glucose as a substrate for the growth of the parasite in the haemolymph (Stentiford et al., 2001) .
The basal level of cHH in the haemolymph of P. elegans was 1.13±0.28·pmol·ml -1 (12±0.3·ng·ml -1 ), which is higher than in the species discussed above. This could depend on the species tested or, in the presence of a similar cHH eyestalk content and release, on a smaller volume of the body-fluid compartment and possibly slower turnover of the circulating hormone. Therefore, further information is needed about the time course and fine mechanisms that regulate the release of cHH, its binding to receptors, and about the half-life and the catabolism of this hormone in the haemolymph in species belonging to different taxa and/or of different inner-fluidcompartment volumes.
In conclusion, the results presented in the present study are the first data that: (1) relate the release of cHH from the eyestalk, the circulating hormone level and the consequent glycaemic response to stress; (2) provide evidence of the Stress-induced variations in shrimp hyperglycemic hormone interference by Hg 2+ on the regulation of this mechanism; (3) confirm the dose-related pathway that leads to variation of blood glucose as a quantitative biomarker of environmental quality, even at sublethal toxicant concentration. This joint research project was supported by grant no. 4C186 and 6D4 from the Italian MiPAF to E.A.F., and by grant from MURST 'Giovani Ricercatori' project to S.L. This work was also part of the Ph.D. research project of S.L. We are indebted to Shoreline srl for supporting these several projects on crustacean ecotoxicology. Special thanks for a reliable supply of animals to Mr Reggani.
